Blueshift Asset Management »

Catalyst Pharmaceutical Partners shares owned by Blueshift Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Blueshift Asset Management from 13F filings

Historical chart of Blueshift Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Blueshift Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $367k 15k 24.76
2022-03-31 $91k 11k 8.32
2019-12-31 $212k 57k 3.75

More positions owned by Blueshift Asset Management

Ishares Tr Russell 2000 Etf (IWM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Etsy (ETSY)
Avis Budget (CAR)
Match Group (MTCH)
O'reilly Automotive (ORLY)
Five Below (FIVE)
Murphy Usa (MUSA)
Equifax (EFX)
CarMax (KMX)
Nike CL B (NKE)
Walt Disney Company (DIS)
Affirm Hldgs Com Cl A (AFRM)
Target Corporation (TGT)
Royal Caribbean Cruises (RCL)

View all positions for Blueshift Asset Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
Vanguard Capital Management
American Century Companies
Deerfield Management Company
Dimensional Fund Advisors
Bank of America Corporation
Geode Capital Management
Morgan Stanley
Vanguard Portfolio Management
Renaissance Technologies
Royce & Associates
Henderson Group
Robeco Investment Management
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners